> All News
> BASL News
> Hepatology News
> Nurse News
> Trainee News
> Transplant News
News Articles 51 - 60 of 160
The tenure of a number of BASL Committee Posts will come to an end in September 2019. As such, BASL are now seeking expressions of interest for the following 5 positions:
The BASL Treasurer is elected by the membership and can serve for up to three years, and may be re-elected once. The Treasurer is also a member of the BLTG Committee.
The Treasurer has the following duties:
- To represent the Association in financial negotiations with third parties together with the Secretary or any other person designated for the task by the Governing Board;
- To oversee the collection and distribution of money on behalf of the Association and keep records of all transactions;
- To engage and supervise an accountant who will keep the books of the Association;
- To present the annual accounts, consisting of the profit and loss statement and balance sheet, to the Business Meeting;
- To present the current accounts to the Governing Board.
The newly elected or re-elected Treasurer will take up the role at the end of the Business Meeting of the Association in September 2019.
The Secretary Elect is elected by the membership and will shadow the BASL Secretary from October 2019, taking up the role of Secretary at the end of the Business Meeting of the Association in September 2020.
The Secretary is the Chief Executive of the Association, serves for two years, and may be re-elected once. The Secretary is responsible for running the administrative tasks pertaining to his/her function and will work closely with the Secretariat, which is appointed by the Governing Board.
British Viral Hepatitis Group (BVHG) Committee Chair
The BVHG Chair is elected by the BASL / BVHG membership to serve for a period of up to three year’s and may be re-elected once.
The BVHG is commissioned by the Governing Board to:
- Promote research and the exchange of scientific information concerning viral hepatitis;
- Foster multicentre scientific studies pertaining to viral hepatitis within the UK;
- Promote education of physicians, surgeons, clinical nurse specialists and scientists with regard to viral hepatitides and their management;
- Promote interaction between clinical disciplines to promote good care of patients and foster research and clinical trials.
The newly elected BVHG Commitee Chair will take up the role in December 2019 and will have a handover with the current Chair.
Educational and Training Councillor
The BASL Committee has two Educational and Training Councillors and one of these posts is up for election. The post is elected by the membership to serve for a period of four years and may be re-elected once. In addition to their role on the Governing Board, the Education and Training Councillors are responsible for Educational tasks as defined by the Governing Board, such as supporting the School of Hepatology.
The newly elected Education and Training Councillor will take up the role at the end of the Business Meeting of the Association in September 2019.
The Scientist Representative is elected by the membership to serve for a period of up to three years and may be re-elected once.
In addition to his/her role on the Governing Board, the Scientist Representative is responsible for the organisation and programme for the annual Basic Science Retreat meeting. This post is a non-clinical committee post.
The newly elected Scientist Representative will take up the role at the end of the Business Meeting of the Association in September 2019.
All of the above posts, with the exception of Secretary Elect, shall be registered with Companies House in the UK as a Director of BASL and registered with the Charities Commission as a Trustee.
Please send your nominations, clearly stating the position that your nomination is for, to the BASL Secretariat at email@example.com by the deadline of 23:59 on Monday 17th June 2019.
Candidates wishing to be considered for election will require one BASL member to propose them and a second BASL member to confirm their suitability for the role in writing.
If more than one candidate is nominated, the Secretariat will arrange for an election of all members. He/she will be elected by simple majority of those members voting.
A personal statement, containing no more than approx. 300 words, will be required from the candidate should an election need to take place.
The newly elected posts will be announced at the next Business Meeting of the Association during BASL2019 in September.
If you need any more information, please do not hesitate to contact firstname.lastname@example.org .
Deadline: 09:00 Monday 3rd June 2019
The Andy Burroughs Young Investigator Award was set up in honour of the late Professor Andrew Burroughs, who sadly passed away in March 2014. Professor Burroughs was an eminent and world renowned Professor of Hepatology and Consultant Physician/Hepatologist and among his many achievements was his significant contribution to liver transplantation.
The winner of the award will deliver the prize lecture at the BLTG Transplant Meeting which this year is taking place at the University of Strathclyde, Glasgow between 17th - 18th September 2019. The winner will also receive free registration to the meeting and £1,000.
This prize is awarded to young investigators, scientific or clinical, who are in training or within 2 years of taking up consultant positions (or equivalent), with an interest in liver transplantation.
How to Apply
Please send one A4 sheet outlining the research and another A4 sheet listing up to 5 related publications.
Please send submissions to email@example.com before the deadline of 09:00 on Monday 10th June 2019.
Deadline: 09:00 Monday 3rd June 2019
Each year BASL presents the Dame Sheila Sherlock research prize, one of the highlights of the annual meeting. This prize is awarded annually to recognise the enormous contribution of Dame Sheila Sherlock to the development of Hepatology as a discipline in its own right.
When Dr Sherlock started her medical career, little was known about liver disease. Her work helped to establish hepatology as a medical specialty. She pioneered the use of needle liver biopsy, which had been used purely as a research tool, based on the technique of Sir John McMichael; this improved understanding of the pathology of liver disease and is used in the diagnosis of liver diseases today. The liver unit that she set up at the Royal Free Hospital became the centre for both research into liver disease and the education of trainees in the specialty.
Dame Sheila was involved in the foundation of the British Liver Club in 1961, which subsequently evolved into The British Association for the Study of the Liver (BASL). She was one of our past presidents and the first recipient of The BASL Distinguished Service Award.
The winner of the award will deliver a 30 minute lecture presenting their research during the BASL Annual Meeting, 18-20 September 2019 at the University of Strathclyde, Glasgow. The prize is free registration to the meeting, a place at the Annual Dinner and £1,000.
In keeping with Dame Sheila’s enthusiasm for fostering young researchers, this eponymous research prize is awarded to young investigators without substantive posts in either medicine or science for their contributions in the field of hepatology research.
How to apply
Please send one A4 sheet outlining your research and another A4 sheet listing up to 5 related publications.
Please send submissions to firstname.lastname@example.org before the deadline of 09:00 on Monday 10th June 2019.
CLDF SUPPORT FOR 2 RESEARCH PROJECTS REQUIRING PATIENT AND PUBLIC INVOLVEMENT
Are you a researcher interested in:
- Childhood/paediatric liver conditions
- Care of children with a liver condition
- Paediatric liver transplantation
- Psychological and social impact on those affected by a paediatric liver condition
Please note: Where appropriate applications for other paediatric chronic/long term conditions will be considered if the experience of our members would benefit the study
CLDF have recently developed a research hub which aims to increase and support patient and public involvement through our network of research hub members. Members are parents, carers, family members and young people affected by childhood liver conditions who have an interest in research design and supporting promotion of findings.
During the research hub trial stage, we are offering to support 2 research projects in 2019 which would benefit from patient and public involvement. If you would like to take advantage of this opportunity visit https://childliverdisease.org/information-for-researchers/ to download the short application form or call 0121 212 6029. Deadline for applications is 12th July 2019 at 5pm.
Gilead Sciences are pleased to announce the launch of five new global grants programs to continue to support investigator-sponsored research in chronic hepatitis C virus (HCV) and hepatitis B virus (HBV), HCV and HIV co-infection, non-alcoholic steatohepatitis (NASH) and primary sclerosing cholangitis (PSC). The programs seek to address pressing unmet patient needs in liver diseases, including improving screening and linkage to care, simplifying HCV testing and treatment, developing innovative referral pathways to help patients with NASH, addressing gaps in HBV care for special populations and understanding PSC epidemiology.
For more information on Gilead’s 2019 liver diseases grants programs, please visit https://www.gilead.com/science-and-medicine/research/investigator-sponsored-research .
The 2019 grant programs are:
HCV STAT (Simplification and Test and Treat Strategies toward HCV Elimination)
This program is focused on simplifying HCV care delivery and implementing test and treat strategies to overcome barriers to patient care.
Applications will be accepted from April 11 to June 30, 2019.
HIV/HCV NoCo (No Co-Infection)
This program is focused on investigating strategies to link patients living with HCV and HIV co-infection to HCV treatment.
Applications will be accepted from May 1 to June 14, 2019.
NASH Models of Care
This program will be focused on investigating care pathways between multidisciplinary providers for screening, identifying, and helping to refer, high-risk patients living with NASH, to appropriate medical care.
Applications will be accepted from June 3 to July 15, 2019.
HBV CARE (Linkage to CARe & Epidemiology in Special Populations)
This program will be focused on improving linkage to care among underserved populations and analysing or identifying data gaps in HBV epidemiology in specific demographics or geographies.
Applications will be accepted from August 1 to September 15, 2019.
PSC PACE (PrimAry Sclerosing Cholangitis Epidemiology)
This program will be focused on identifying gaps in PSC epidemiology data and improving understanding of the cascade of care.
Applications will be accepted from September 16 to October 11, 2019.
Vacancy for Senior Lecturer in Hepatology and Consultant Hepatologist at St George's
St George's University of London and the trust's Department of Gastroenterology and Hepatology are looking to appoint an exceptional individual to this exciting new post. The post has been created for a self-motivated clinical academic to establish an independent research program at St George’s University of London, with clinical duties in a supportive and friendly department.
Please click on the link below:
Closing date: 12th June 2019
Interview date: 27th June 2019
The Royal College of Physicians has 2 Vacancies that members might be interested in:
Closing date: 4.00pm on Friday 3 May 2019.
2. Research & Academic Medicine committees: Two senior research-active clinicians - click here to view the commitee roles on the RCP website.
Closing date: Friday 3 May 2019.
Applications are invited for two Senior Clinical Fellow posts in Hepatology and Liver Transplantation for twelve months, from 02 September 2019 to 04 September 2020 at Addenbrooke’s Hospital, Cambridge University Hospitals NHS Foundation Trust.
These posts are geared towards furthering a career in Hepatology. It is available to applicants who are within Gastroenterology/Hepatology training and wishing to seek an out of programme training/research period or to those who are seeking additional experience in tertiary Hepatology and Liver Transplantation following completion of training. The post could be extended subject to satisfactory progress particularly if pursuing out of programme research.
A breadth of subspecialist learning opportunities are available, depending on the applicants preference, which include tertiary level Hepatology, Liver Transplantation, Research or Management. For example in NASH, alcoholic hepatitis, HCC and PBC, we can offer involvement in translational research projects, in collaboration with research partners on the Cambridge Biomedical Campus, as well as involvement in Clinical Trials.
The successful candidates would both contribute to the Hepatology on call rota (1 in 8) and one of the posts will contribute no more than 4 weeks per six months to the general medical take rota.
These posts are not accredited as part of a speciality training programme but could be used for purposes as stated above.
Applicants must have demonstrable skills in listening, reading, writing and speaking in English that enable effective communication about medical topics with patients and colleagues, as set out in the GMC’s Good Medical Practice (2013).
Informal enquiries about this post should be addressed to Bill Griffiths (Specialty lead for Hepatology) at email@example.com or Dr Victoria Snowdon (Consultant Hepatologist) at firstname.lastname@example.org .
Deadline - end of April 2019.
BASL has set up a number of Special Interest Groups (SIGs), which are linked to the NIHR’s Clinical Research Network (CRN) topic areas.
The End of Life SIG has been active for one year, with an initial lead appointed by the BASL Committee. BASL is now seeking nominations for an elected Lead for this SIG.
• All nominees should be members of the End of Life SIG, as a BASL member or as an associate member of BASL through being a member of the SIG
• Each nominee should have a proposer and seconder, who should also be BASL members or associate members through the End of Life SIG
• The initial Lead can stand for election once
• Should a contested election be held, BASL / End of Life SIG members may vote in this
• The elected Lead will serve for two years, when there will be a further election.
Please send nominations to the BASL Secretariat at Samantha@basl.org.uk by 17:00 on 22nd March 2019
If more than one candidate is nominated, the Secretariat will arrange for an election, in which all BASL / End of Life SIG members may vote
Should an election be required, candidates will need to submit a personal statement of up to 300 words
The successful candidate will be elected by a simple majority of those members voting
Any queries should be addressed to Samantha@basl.org.uk.
The role of the SIG Lead
A SIG is expected to meet at least once a year. The BASL secretariat provides administrative support for SIGs, which includes creating and maintaining SIG member databases, arranging meetings and associated materials, and arranging publicity.
The role of the SIG Lead includes:
• Chairing SIG meetings and co-ordinating actions to be pursued
• Helping to co-ordinate bids for funding for trials and other research, and linking with the NIHR and other funders
• Ensuring the SIG is recognised and supported within the Metabolic CRN topic area
• Reporting on SIG activities to BASL, in particular via liaison with BASL’s Research Subcommittee.
The UK Obstetric Surveillance System (UKOSS) is collecting data during pregnancy for women with Cirrhosis who become pregnant. This is an attempt to gather data on both numbers and outcomes of women with Pregnancy and Chronic Liver Disease in the UK.
The data collected so far can be viewed on the map here > Download UKOSS map.pdf
The lead investigators are Professor Cath Williamson and Professor Michael Heneghan.
The ask from Hepatologists & BASL Membership is to let patients know who are pregnant to ask their local Obstetric service to include them in the data collection for the UKOSS Study. They are keen for liver centres that have still not reported any cases to be involved.
The Surveillance Period end on 31st May 2019.
Thank you for your help.